ArticleFrontiers in oncology2022

Fruquintinib in Combination With PD-1 Inhibitors in Patients With Refractory Non-MSI-H/pMMR Metastatic Colorectal Cancer: A Real-World Study in China.

Miaomiao Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.